Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Chaintreuil

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|May 5, 2023
The generation, activation, and polarization of monocyte-derived macrophages in human malignanciesPaul Chaintreuil, Emeline Kerreneur, Maxence Bourgoin, et al.
Cancers|July 26, 2020
Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor ProgressionMaría Alejandra Parigiani, Anett Ketscher, Sylvia Timme, et al.
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.
Iscience|February 25, 2025
Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress <i>in vivo</i>Juan A Garcia-Sanchez, Estelle Bonnet, Céline Loubatier, et al.
Scientific Reports|January 12, 2018
IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potentialSonia Boulakirba, Anja Pfeifer, Rana Mhaidly, et al.
EMBO Reports|June 11, 2025
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cellsKhansa Saadallah, Benoît Vianay, Louise Bonnemay, et al.
Nature Microbiology|January 12, 2021
Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in miceOcéane Dufies, Anne Doye, Johan Courjon, et al.
The Journal of Experimental Medicine|August 30, 2024
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activationAnne Doye, Paul Chaintreuil, Chantal Lagresle-Peyrou, et al.
Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 5, 2023
The generation, activation, and polarization of monocyte-derived macrophages in human malignanciesPaul Chaintreuil, Emeline Kerreneur, Maxence Bourgoin, et al.
Cancers|July 26, 2020
Conditional Gene Targeting Reveals Cell Type-Specific Roles of the Lysosomal Protease Cathepsin L in Mammary Tumor ProgressionMaría Alejandra Parigiani, Anett Ketscher, Sylvia Timme, et al.
Oncoimmunology|March 7, 2022
Reprogramming monocyte-derived macrophages through caspase inhibitionPaul Chaintreuil, Lucie Laplane, Florian Esnault, et al.
Iscience|February 25, 2025
Evolutionary conserved regulation of TFEB stability by the E3 ubiquitin ligase WWP2 modulates response to stress <i>in vivo</i>Juan A Garcia-Sanchez, Estelle Bonnet, Céline Loubatier, et al.
Scientific Reports|January 12, 2018
IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potentialSonia Boulakirba, Anja Pfeifer, Rana Mhaidly, et al.
EMBO Reports|June 11, 2025
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cellsKhansa Saadallah, Benoît Vianay, Louise Bonnemay, et al.
Nature Microbiology|January 12, 2021
Escherichia coli Rho GTPase-activating toxin CNF1 mediates NLRP3 inflammasome activation via p21-activated kinases-1/2 during bacteraemia in miceOcéane Dufies, Anne Doye, Johan Courjon, et al.
The Journal of Experimental Medicine|August 30, 2024
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activationAnne Doye, Paul Chaintreuil, Chantal Lagresle-Peyrou, et al.
Nature Cancer|June 6, 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemiaKevin H Lin, Justine C Rutter, Abigail Xie, et al.
Pageof 1